Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training in Long-Distance Runners (IRCT-LDR)
Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training Modalities: A Comprehensive Examination of Conditioning in Long-Distance Runners
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Long-distance running places substantial physiological and mechanical demands on athletes. Appropriate conditioning is therefore important for developing the capacity to tolerate training stress, recover effectively, and maintain or improve running performance. Different conditioning modalities may impose distinct physiological and mechanical demands, which may result in differences in immediate exercise responses, post-exercise recovery, training load, and longer-term adaptation.
This randomized controlled trial will compare three conditioning modalities. Fartlek training, hill circuit training, and roll-on training in well-trained long-distance runners. Twenty-one eligible runners will be randomly allocated to one of three parallel training groups: the Fartlek Training Group, Hill Circuit Training Group, or Roll-On Training Group. Each group will complete its assigned conditioning modality for 12 weeks, comprising 24 prescribed training sessions.
The study will examine three dimensions of response to conditioning. Immediate responses will include physiological and perceptual responses measured during or immediately after training. Residual responses will focus on recovery-related responses during the 24 hours following conditioning sessions. Cumulative responses will examine changes that develop over repeated exposure to the training intervention, including changes in running performance and aerobic fitness.
Repeated measurements will be collected throughout the intervention to characterize responses to the three conditioning modalities. Measures will include heart rate, blood lactate concentration, rating of perceived exertion, delayed-onset muscle soreness, recovery and wellness indicators, internal training load, 5-km time-trial performance, and VO₂max. Training-load measures will be derived from session rating of perceived exertion and session duration and will be used to characterize the training demands accumulated during the intervention.
The study will compare the response patterns among the three intervention groups to determine whether Fartlek, hill circuit, or roll-on training produces different immediate, residual, and cumulative responses in well-trained long-distance runners. The findings are intended to contribute evidence for the selection and progression of conditioning modalities while considering training stimulus, recovery, and performance-related responses.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Awoke Tibebu, MSc.
- Número de teléfono: +251912073305
- Correo electrónico: awoket27@gmail.com
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Male long-distance runners aged 18-25 years VO₂max greater than 60 mL/kg/min Weekly training volume of at least 60 km Training experience of at least 4 years Mercier score greater than 600 Currently engaged in regular long-distance running training Willing to participate in the 12-week training intervention Able to complete all required testing and monitoring procedures Provides written informed consent to participate in the study
Exclusion Criteria:
Current musculoskeletal injury that prevents participation in training or testing Known cardiovascular, respiratory, metabolic, or other medical condition that limits strenuous exercise Current illness or condition that prevents participation in the intervention Use of medication or other treatment that may substantially affect exercise performance or physiological responses Failure to meet the required training or eligibility criteria Planned absence that would prevent adequate participation in the intervention Withdrawal of informed consent Any condition identified by the research team that makes continued participation unsafe
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Fartlek Training Group (FTG)
A structured Fartlek running training intervention administered for 12 weeks to trained long-distance runners.
The intervention consists of planned variable-intensity running bouts with prescribed duration, repetitions, running intensity, recovery periods, and progressive workload according to the study protocol.
Training sessions will be supervised and standardized across participants.
|
A structured variable-intensity running intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, alternating faster and slower running at prescribed intensities, and prescribed recovery periods.
Running duration, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol.
Training sessions are supervised, and exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
|
Experimental: Hill Circuit Training Group (HCTG)
Participants assigned to the Hill Circuit Training Group (HCTG) will receive the prescribed Hill Circuit training intervention during the 12-week randomized controlled trial.
The intervention consists of structured hill-running and circuit-based training designed for trained long-distance runners.
Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
|
A structured hill-running and circuit-based training intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, repeated uphill running bouts, running-based circuit exercises, and prescribed recovery intervals.
Hill gradient, running duration, repetitions, exercise intensity, recovery intervals, and workload progression are standardized according to the study protocol.
Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
|
Experimental: Roll-On Training Group (ROTG)
Participants assigned to the Roll-On Training Group (ROTG) will receive the prescribed Roll-On training intervention during the 12-week randomized controlled trial.
The intervention consists of structured progressive running sessions designed for trained long-distance runners.
Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
|
A structured progressive running intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, controlled running with planned gradual increases and decreases in running speed, and prescribed recovery periods where applicable.
Running duration, speed progression, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol.
Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
5-km Time-Trial Performance
Periodo de tiempo: Baseline week 6 and Week 12
|
Change in 5-km time-trial completion time from baseline to Week 6 and Week 12, comparing the Fartlek Training Group (FTG), Hill Circuit Training Group (HCTG), and Roll-On Training Group (ROTG).
|
Baseline week 6 and Week 12
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
VO₂max
Periodo de tiempo: Baseline, Week 6, and Week 12
|
Change in maximal oxygen uptake (VO₂max), measured in mL/kg/min, from baseline to Week 6 and Week 12, comparing FTG, HCTG, and ROTG.
|
Baseline, Week 6, and Week 12
|
|
Blood Lactate Concentration
Periodo de tiempo: Immediately pre-training and post-training during intervention sessions in Weeks 1-12
|
Change in blood lactate concentration, measured in mmol/L, immediately following prescribed conditioning sessions to characterize the acute physiological response to Fartlek, Hill Circuit, and Roll-On training.
|
Immediately pre-training and post-training during intervention sessions in Weeks 1-12
|
|
Rating of Perceived Exertion (RPE)
Periodo de tiempo: Immediately after each training session during Weeks 1-12
|
Session rating of perceived exertion will be measured using the OMNI perceived-exertion scale immediately following each conditioning session.
|
Immediately after each training session during Weeks 1-12
|
|
Heart Rate Response
Periodo de tiempo: During each training session during Weeks 1-12
|
Change in average and maximum heart rate during prescribed conditioning sessions to characterize the acute cardiovascular response to Fartlek, Hill Circuit, and Roll-On training.
|
During each training session during Weeks 1-12
|
|
Complete Blood Count (CBC)
Periodo de tiempo: Baseline, Week 6, and Week 12
|
Change in selected hematological parameters, including hemoglobin, hematocrit, red blood cell count parameters.
|
Baseline, Week 6, and Week 12
|
|
5-km Performance Score
Periodo de tiempo: Baseline and Week 12
|
Change in performance score calculated using the applicable World Athletics scoring table based on 5-km time-trial performance from baseline to Week 12, comparing FTG, HCTG, and ROTG.
|
Baseline and Week 12
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Delayed-Onset Muscle Soreness (DOMS)
Periodo de tiempo: Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
|
Change in self-reported muscle soreness following each prescribed conditioning session to assess post-exercise muscular recovery.
|
Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
|
|
Recovery and Wellness
Periodo de tiempo: Before and 24 hours after each conditioning session during Weeks 1-12
|
Change in recovery and wellness indicators, including sleep duration, sleep quality, fatigue, stress, mood, and overall wellness score, assessed following conditioning sessions.
|
Before and 24 hours after each conditioning session during Weeks 1-12
|
|
Acute Training Load
Periodo de tiempo: Weeks 1-12
|
Weekly acute internal training load calculated from accumulated session training loads, where session training load is calculated as session duration multiplied by session rating of perceived exertion (sRPE).
|
Weeks 1-12
|
|
Chronic Training Load
Periodo de tiempo: Weeks 4-12
|
Chronic internal training load calculated as the rolling 4-week average of weekly training load during the intervention.
|
Weeks 4-12
|
|
Training Monotony
Periodo de tiempo: Weeks 1-12
|
Weekly training monotony calculated as the mean daily training load divided by the standard deviation of daily training load within each training week.
|
Weeks 1-12
|
|
Training Strain
Periodo de tiempo: Weeks 1-12
|
Weekly training strain calculated as weekly training load multiplied by training monotony during the 12-week intervention.
|
Weeks 1-12
|
|
Freshness Index
Periodo de tiempo: Weeks 1-12
|
Weekly freshness index calculated as chronic training load minus acute training load to characterize changes in training readiness during the intervention.
|
Weeks 1-12
|
|
Acute:Chronic Workload Ratio (ACWR)
Periodo de tiempo: Weeks 4-12
|
Weekly acute:chronic workload ratio calculated as acute training load divided by chronic training load during the intervention.
|
Weeks 4-12
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Director de estudio: Alemayehu, PHd, University of Gonder
- Silla de estudio: Gashaw, PHd, Bahir Dar University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- IRERC-19-2025
- bdu1500226 (Otro identificador: Bahir Dar University)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .